Management of severe pain in the prehospital setting has been a controversial topic since the development of the organized delivery of prehospital emergency care. Concerns regarding adverse effects from opioid administration such as respiratory depression and hypotension, as well as concerns about symptom masking impeding physician examination, have led to systemic prehospital oligoanalgesia. Despite a 2003 evidence-based position paper from the National Association of EMS Physicians (NAEMSP) emphasizing the importance of adequate pain management, multiple subsequent studies have demonstrated the ongoing existence of prehospital oligoanalgesia.Citation1–5
Morphine has been the primary opioid analgesic available for prehospital use in the United States dating back to the Civil War. As early as World War II, however, concerns began surfacing regarding sequelae when morphine is administered to trauma patients.Citation6 Fentanyl, an opioid with a wider safety profile than morphine, was introduced into some prehospital formularies, but other pharmacologic options need to be explored. Many current civilian EMS protocols, such as early tourniquet application, have been adapted from military practice; it is time to make ketamine analgesia a more widespread addition to that list, as presently only a limited number of leading edge EMS systems allow the use of ketamine by Advanced Life Support level providers for analgesia.Citation7
Initial experience in the United States military was limited to Special Operations medical providers with an expanded scope of practice. Ketamine has proven remarkably versatile; it can be used as a standalone analgesic or given alongside either opioids or benzodiazepines for a synergistic effect.Citation8,9 Indeed, many now refer to ketamine as the Swiss Army Knife for subanesthetic application.Citation10
In 2012 the Defense Health Board approved the use of ketamine for prehospital analgesia across the Department of Defense (DoD) in accordance with Tactical Combat Casualty Care (TCCC) guidelines.Citation11,12 Most DoD published experience with prehospital ketamine analgesia is focused on case studies, but the safety profile is nevertheless impressive with minimal reported complications. The analgesia update to the TCCC guidelines provides an excellent review of the available literature on the topic.Citation13
In a series of military and civilian studies, ketamine was compared to a variety of opioid analgesics including the previous gold standard of morphine, the increasingly widely used fentanyl, and in one study pentazocine. In each case ketamine provided equally effective pain relief as the opioid agents.Citation14–16 Additionally, whereas opiates can cause hypotension, ketamine both stimulates catecholamine release and inhibits their reuptake, often causing an increase in blood pressure.Citation15
These properties open a new frontier in prehospital analgesia, as there traditionally have been limited options for prehospital pain management of the hypotensive, hemorrhaging patient. Ketamine is not restricted to managing pain in traumatic cases of hemorrhage either. It is also appropriate for patients whose pain and hemorrhage are secondary to medical etiology.
Civilian hospital-based literature and military research both demonstrate the wide safety profile for ketamine. Anecdotal overdoses of 100 times the intended dose have been reported with no long-term sequelae.Citation17 Ketamine also does not have the respiratory depressant effects that many opioids do.Citation15 These additional properties make ketamine an ideal choice for analgesia for virtually all indications.
Ketamine has historically been considered to have two major drawbacks.The most famous of these is the specter of emergence reactions. The American College of Emergency Physicians (ACEP) discourages ketamine use in patients with any psychosis history based on evidence showing that ketamine precipitates psychotic episodes in patients with schizophrenia.Citation18,19 Among patients without such history, however, clinically significant emergence reactions occur in less than 2% of pediatric patients.Citation20 For adults, the incidence ranges from 0 to 30%.When emergence reactions do occur, administration of a benzodiazepine provides simple resolution without sequelae.Citation19
The other reservation about ketamine use is the risk that it could precipitate an increase in intracranial pressure (ICP). Recent research has demonstrated that this concern is unfounded, and ACEP has endorsed the use of ketamine in patients with traumatic brain injury (TBI).Citation19,21 Indeed, there is now emerging literature examining TBI/ICP instances where Ketamine is showing a potential neuro protective effect.Citation22 Ketamine's effect on intraocular pressure is less clear, however, and ACEP considers open globe injury a relative contraindication for ketamine use.Citation19,23,24
Extreme caution should also be exercised in patients experiencing a hypertensive crisis or ischemic chest pain, as they are likely to be intolerant of a sudden increase in blood pressure. These patients would be better served by an opioid analgesic that will not increase cardiac workload.Citation19,25
While ketamine is indeed an ideal analgesic under virtually all conditions, in order to provide optimal patient care it should not be the sole medication available. Field providers should have the option to use an opioid such as fentanyl in lieu of ketamine for a severely hypertensive patient or one with a known psychosis history. It would also be wise to have a benzodiazepine available to treat emergence reactions if one occurs.
At the moment, ketamine is only United States Food and Drug Administration (FDA)-approved for use in general anesthesia and procedural sedation. NAEMSP takes the official position, however, that medical directors may authorize any legal medication for off-label use.Citation26 Such treatment protocols are widely accepted in EMS and include nasal naloxone administration, administration of sublingual nitroglycerin to patients with early myocardial infarctions, and administration of glucagon to counteract beta blocker overdoses.Citation27–29
Three questions must be answered before adding a new medication to an EMS service's drug formulary or expanding the indications for a drug currently being carried:
Does it work?
Does it offer an advantage over what is currently on the market?
Is it safe?
For ketamine analgesia, the answer to all three questions is yes.
References
- Alonso-Serra HM, Wesley K. Peehospital pain management. Prehosp Emerg Care. 2003;7(4):482–8. doi:10.1080/312703002260
- Albrecht E, Taffe P, Yersin B, Schoettker P, Decosterd I, Hugli O. Undertreatment of acute pain (oligoanalgesia) and medical practice variation in prehospital analgesia of adult trauma patients: A 10 yr retrospective study. Brit J Anaesth. 2012;110(1):96–106. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23059961
- Samuel N, Steiner I, Shavit I. Prehospital pain management of injured children: a systematic review of current evidence. Am J Emerg Med. 2015;33(3):451–4. Available at: http://www.ncbi.nlm.nih.gov/pubmed/25572641
- Galinski M, Ruscev M, Gonzalez G, et al. Prevalence and management of acute pain in prehospital emergency medicine. Prehosp Emerg Care. 2010;14(3):334–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20507221
- Marinangeli F, Narducci C, Ursini M, et al. Acute pain and availability of analgesia in the prehospital emergency setting in Italy: A problem to be solved. Pain Practice. 2009;9(4):282–8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19490463
- Beecher HK. Delayed morphine poisoning in battle casualties. J Am Med Assoc. 1944;124(17):1193. doi:10.1001/jama.1944.62850170001007
- Hennepin County, MN. Hennepin County EMS System Advanced Life Support Protocols. Available at: http://www.hennepin.us/-/media/hennepinus/business/work-with-hennepin-county/ems/als-protocols-2014.pdf
- PFC Working Group. Analgesia & Sedation, February, 2014. Special Operations Medical Association, Overland KS; https://prolongedfieldcare.files.wordpress.com/2014/11/pfc-wg-analgesia-and-sedation-comments-feb-14.docx
- Special Operations Medicine's Podcast, Justin Ball and Lt. Col. Reed Jim (Ret). Ketamine and PFC, September 14, 2015.
- Special Operations Medicine's Podcast, Weingart Scott. Ketamine for Prolonged Field Care Part 1, May 29, 2015.
- Fisher A, Rippee B, Shehan H, Conklin C, Mabry R. Prehospital analgesia with ketamine for combat wounds: A case series. J Spec Oper Med. 2014;14(4):11–7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/25399363
- Defense Health Board. Prehospital Use of Ketamine in Battlefield Analgesia 2012–03. In: Department of Defense, 2012. Defense Health Board, Falls Church, VA http://www.specialoperationsmedicine.org/documents/TCCC/06%20TCCC%20Reference%20Documents/DHB%20Memo%20120308%20Ketamine.pdf
- Butler F, Kotwal R, Buckenmaier C, et al. A triple-option Analgesia plan for tactical combat casualty care: TCCC guidelines change 13–04. J Spec Oper Med. 2014;14(1):13–25. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24604434
- Miller JP, Schauer SG, Ganem VJ, Bebarta VS. Low-dose ketamine vs morphine for acute pain in the ED: a randomized controlled trial. Am J Emerg Med. 2015;33(3):402–8. doi:10.1016/j.ajem.2014.12.058
- Shackelford SA, Fowler M, Schultz K, et al. Prehospital pain medication use by U.S. Forces in Afghanistan. Military Medicine. 2015;180(3):304–9. doi:10.7205/milmed-d-14-00257
- Losvik OK, Murad MK, Skjerve E, Husum H. Ketamine for prehospital trauma analgesia in a low-resource rural trauma system: A retrospective comparative study of ketamine and opioid analgesia in a ten-year cohort in Iraq. Scan J Trauma, Resusci Emerg Med. 2015;23(1). doi:10.1186/s13049-015-0176-1
- Green SM, Clark R, Hostetler MA, et al. Inadvertent ketamine overdose in children: Clinical manifestations and outcome. Ann Emerg Med. 1999;34(4):492–7. doi:10.1016/s0196-0644(99)80051-1
- Lahti AC, Koffel B, LaPorte D, Tamminga CA. Subanesthetic doses of Ketamine stimulate Psychosis in schizophrenia. Neuropsychopharmacology. 1995;13(1):9–19. doi:10.1038/sj.npp.1380271
- Green SM, Roback MG, Kennedy RM, Krauss B. Clinical practice guideline for emergency department Ketamine Dissociative Sedation: 2011 update. Ann Emerg Med. 2011;57(5):449–61. doi:10.1016/j.annemergmed.2010.11.030
- Green SM, Roback MG, Krauss B, et al. Predictors of Emesis and recovery agitation with emergency department Ketamine Sedation: An individual-patient data Meta-Analysis of 8, 282 children. Ann Emerg Med. 2009;54(2):171–80.e4. doi:10.1016/j.annemergmed.2009.04.004
- Zeiler F, Teitelbaum J, West M, Gillman L. The ketamine effect on ICP in traumatic brain injury. Neurocrit Care. 2014;21(1):163–73. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24515638
- Special Operations Medicine's Podcast, Weingart Scott, Ketamine for Prolonged Field Care Part 1, May 29, 2015. Special Operations Medical Association Prolonged Field Care Working Group's Podcast. Overland, KS. https://prolongedfieldcare.org/prolonged-field-care-working-group-youtube-channel/
- Drayna PC, Estrada C, Wang W, Saville BR, Arnold DH. Ketamine is not associated with elevation of intraocular pressure during procedural sedation. 2011;30(7). Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3761376/
- Wadia S, Bhola R, Lorenz D, et al. Ketamine and intraocular pressure in children. Ann Emerg Med. 2014;64(4):385–8.e1. doi:10.1016/j.annemergmed.2014.01.029
- “Ketamine Hydrochloride Injection, USP Rx Only - Hospira.” Ketamine Hydrochloride. Available at: https://www.hospira.com/en/images/EN-3179_tcm81-91772.pdf. October 20, 2016.
- National Association of EMS Physicians. Off-label use of medical products. Prehosp Emerg Care. 2011;15(3):419–9. doi:10.3109/10903127.2011.561417
- “FDA Moves Quickly to Approve Easy-to-use Nasal Spray to …” Food and Drug Administration. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnounceme-nts/ucm473505.htm. October 20, 2016.
- Nitrostat. Nitrostat Drug Information. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021134s005lbl.pdf. October 20, 2016.
- “Information for the Physician Glucagon for Injection (rDNA) ….” Food and Drug Administration. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20928slr010_glucagon_lbl.pdf. October 20, 2016.